The inhibitors were then tested for their ability to enhance the GC-induced expression of the G9a/GLP/HP1γ-dependent genes, the interaction of G9a and GLP with HP1γ and GC-induced apoptosis of the Nalm6 B-ALL cell line. This evidence concerns the gene EHMT2 and acute lymphoblastic leukemia.